Netta Blondheim-Shraga
Directeur Technique/Scientifique/R&D chez BRAINSTORM CELL THERAPEUTICS INC.
Profil
Netta Blondheim-Shraga is currently the Vice President-Research & Development at Brainstorm Cell Therapeutics, Inc. She previously worked as a Study Director at Crown Bioscience, Inc. from 2019 to 2020.
Dr. Blondheim-Shraga has a graduate degree from Tel-Aviv University, an undergraduate degree from The Hebrew University of Jerusalem, and a doctorate from Bar-Ilan University and the Faculty of Medicine.
Postes actifs de Netta Blondheim-Shraga
| Sociétés | Poste | Début |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 12/05/2022 |
Anciens postes connus de Netta Blondheim-Shraga
| Sociétés | Poste | Fin |
|---|---|---|
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | 01/09/2020 |
Formation de Netta Blondheim-Shraga
| Bar-Ilan University | Doctorate Degree |
| Tel-Aviv University | Graduate Degree |
| The Hebrew University of Jerusalem | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
